fda compounding semaglutide enforcement news november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns – Partnership for Safe Medicines National Hispanic Medical Association |

Its all connected your hormones, metabolism, and fertility

Our advice is to speak to your GP about the risks and benefits of GLP-1 medicines before taking them, and only take those prescribed by a healthcare professional. The authors say that further studies evaluating the impact of these medications on pregnancy and unborn babies are warranted

The vendor operates within the research peptide marketplace serving individuals exploring compounds like retatrutide , the novel triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously for metabolic research applications

Form Health executives say patients lose an average of 15% of their body weight at twelve months

Semaglutide GLP-1 Shots for Chronic Weight Management in Las Vegas, NV The FDA has approved once-weekly Semaglutide GLP-1 injections for chronic weight management in obese or overweight adults with at least one weight-related condition

Both medications helped people lose weight and improve other weight-related conditions